Nosocomial transmission of methicillin-resistant Staphylococcus aureus: A blinded study to establish baseline acquisition rates

Infection Control and Hospital Epidemiology

Volumn 24, Issue 6, 2003, Pages 415-421

  Fishbain, Joel T ^a,b   Lee, Joseph C ^a   Nguyen, Honghung D ^a   Mikita, Jeffery A ^a   Mikita, Cecilia P ^a   Uyehara, Catherine F T ^a   Hospenthal, Duane R ^a  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b Infectious Disease Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; NITROFURANTOIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS INFECTION;

EID: 0038341147     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502224     Document Type: Article

References (31)

1. Ayliffe GAJ. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997;24(suppl 1):S74-S79.
2. U.S. Department of Health and Human Services, Public Health Service. Semiannual Report: Aggregated Data From the National Nosocomial Infections Surveillance (NNIS) System: December 2000. Washington, DC: U.S. Department of Health and Human Services; 2000. Available at www.cdc.gov/ncidod/hip/SURVEILL/NNIS.HTM
3. Boetz MB, Kwok R, Garcia JP. Management and epidemiologic analyses of an outbreak due to methicillin-resistant Staphylococcus aureus. Am J Med 1992;92:607-614.
4. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-550.
5. Hartstein A, LeMonte AM, Iwamoto PKL. DNA typing and control of methicillin-resistant Staphylococcus aureus at two affiliated hospitals. Infect Control Hosp Epidemiol 1997;18:42-48.
6. Jernigan JA, Clemence MA, Stott GA, et al. Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later. Infect Control Hosp Epidemiol 1995;16:686-696.
7. Hartstein AI, Denny MA, Morthland VH, LeMonte AM, Pfaller MA. Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect Control Hosp Epidemiol 1995;16:405-411.
8. Wenzel RP, Nettleman MD, Jones RN, Pfaller MA. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am J Med 1991;91 (suppl 3B):221S-227S.
9. Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995;171:614-624.
10. Boyce JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 1991;12:46-54.
11. Murray-Leisure KA, Geib S, Graceley D, et al. Control of epidemic methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 1990;11:343-350.
12. Cohen SH, Morita MM, Bradford M. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med 1991;91(suppl 3B):233S-237S.
13. Jernigan JA, Titus MG, Groschel DHM, Getchell-White SI, Farr BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496-504.
14. Harbarth S, Pittet D. Controlling a long-term, hospital-wide epidemic of methicillin-resistant Staphylococcus aureus strains: experiences from the Geneva university hospital. Hygien und Medizin 1997;22:306-313.
15. 66 Federal Register 56775 (2001) (codified at 45 CFR §46).
16. Kenner J, O'Connor T, Piantanida N, et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003;24:439-444.
17. Harbarth S, Martin Y, Rohner P, Henry N, Auckenthaler R, Pittet D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:43-49.
18. Eveillard M, Eb F, Tramier B, et al. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital. J Hosp Infect 2001;47:116-124.
19. Masaki H, Watanabe H, Degawa S, et al. Significant reduction of methicillin-resistant Staphylococcus aureus bacteremia in geriatric wards after introduction of infection control measures against nosocomial infections. Intern Med 2001;40:214-220.
20. Rao N, Jacobs S, Joyce L. Cost-effective eradication of an outbreak of methicillin-resistant Staphylococcus aureus in a community teaching hospital. Infect Control Hosp Epidemiol 1988;9:255-260.
21. Papia G, Louis M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473-477.
22. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745-1751.
23. Souweine B, Traore O, Aublet-Cuvelier B, et al. Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J Hosp Infect 2000;45:107-116.
24. Cosseron-Zerbib M, Roque Afonso AM, Naas T, et al. A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: evaluation and impact on infectious caused by other micro-organisms. J Hosp Infect 1998;40:225-235.
25. Kotilainen P, Routamaa M, Peltonen R, et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 2001;161:859-863.
26. Girou E, Azar J, Wolkenstein P, Cizeau F, Brun-Buisson C, Roujeau JC. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000;21:583-587.
27. Thompson RL, Cabezudo I, Wenzel R. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. Ann Intern Med 1982;97:309-317.
28. Boyce JM, Jackson MM, Pugliese G, et al. Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994;15:105-113.
29. Layton MC, Hierholzer WJ, Patterson JE. The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol 1995;16:12-17.
30. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598.
31. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999;29:797-800.